AGIOS PHARMACEUTICALS INC's ticker is and the CUSIP is 00847X904. A total of 4 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94 | +123.8% | 3,800 | +153.3% | 0.00% | – |
| Q2 2023 | $42 | +44.8% | 1,500 | +15.4% | 0.00% | – |
| Q1 2023 | $29 | -98.4% | 1,300 | -98.0% | 0.00% | -100.0% |
| Q4 2022 | $1,870 | -99.6% | 66,600 | +332.5% | 0.00% | – |
| Q3 2022 | $435,000 | +3.8% | 15,400 | -18.5% | 0.00% | – |
| Q2 2022 | $419,000 | +22.2% | 18,900 | +60.2% | 0.00% | – |
| Q1 2022 | $343,000 | +11333.3% | 11,800 | +11700.0% | 0.00% | – |
| Q4 2021 | $3,000 | -99.6% | 100 | -99.3% | 0.00% | -100.0% |
| Q3 2021 | $789,000 | +3.0% | 14,000 | +0.7% | 0.00% | 0.0% |
| Q2 2021 | $766,000 | -21.4% | 13,900 | +7254.5% | 0.00% | -50.0% |
| Q1 2021 | $975,000 | +23.1% | 189 | +3.3% | 0.00% | +100.0% |
| Q4 2020 | $792,000 | +890.0% | 183 | +695.7% | 0.00% | – |
| Q3 2020 | $80,000 | -90.8% | 23 | -85.9% | 0.00% | -100.0% |
| Q2 2020 | $871,000 | -43.0% | 163 | -62.2% | 0.00% | -66.7% |
| Q1 2020 | $1,529,000 | -43.6% | 431 | -24.1% | 0.00% | -50.0% |
| Q4 2019 | $2,712,000 | +1423.6% | 568 | +932.7% | 0.01% | +500.0% |
| Q3 2019 | $178,000 | -72.9% | 55 | -58.3% | 0.00% | -50.0% |
| Q2 2019 | $658,000 | -55.2% | 132 | -39.4% | 0.00% | -50.0% |
| Q1 2019 | $1,470,000 | -3.7% | 218 | -34.1% | 0.00% | 0.0% |
| Q4 2018 | $1,526,000 | +17.8% | 331 | +97.0% | 0.00% | 0.0% |
| Q3 2018 | $1,295,000 | -23.5% | 168 | -16.4% | 0.00% | -42.9% |
| Q2 2018 | $1,693,000 | +1310.8% | 201 | +9.2% | 0.01% | +40.0% |
| Q1 2018 | $120,000 | +900.0% | 184 | +253.8% | 0.01% | +400.0% |
| Q4 2017 | $12,000 | – | 52 | +1200.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 4 | -87.9% | 0.00% | – |
| Q2 2017 | $6,000 | -93.8% | 33 | -76.4% | 0.00% | -100.0% |
| Q1 2017 | $97,000 | +977.8% | 140 | +259.0% | 0.00% | +300.0% |
| Q4 2016 | $9,000 | -25.0% | 39 | +14.7% | 0.00% | 0.0% |
| Q3 2016 | $12,000 | +300.0% | 34 | +47.8% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 23 | +43.8% | 0.00% | – |
| Q1 2016 | $2,000 | +100.0% | 16 | +433.3% | 0.00% | – |
| Q4 2015 | $1,000 | -90.0% | 3 | -96.6% | 0.00% | -100.0% |
| Q3 2015 | $10,000 | -79.2% | 89 | +43.5% | 0.00% | -75.0% |
| Q2 2015 | $48,000 | +26.3% | 62 | +14.8% | 0.00% | 0.0% |
| Q1 2015 | $38,000 | -86.6% | 54 | -67.9% | 0.00% | -88.2% |
| Q4 2014 | $284,000 | – | 168 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 66,600 | $1,870 | 0.00% |
| GROUP ONE TRADING, L.P. | 26,700 | $749,736 | 0.00% |
| JPMORGAN CHASE & CO | 208,600 | $5,857 | 0.00% |
| JANE STREET GROUP, LLC | 91,100 | $2,558,088 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |